Product Images Doxorubicin Hydrochloride

This is a medication information sheet for Doxorubicin Hydrochloride Liposome Injection, a sterile cytotoxic agent that must be diluted prior to administration. The medication contains doxorubicin hydrochloride, USP 2mg that must be used in conjunction with 5% Dextrose Injection, USP. The medication is distributed by Sun Pharmaceutical Industries, Inc, and manufactured by Sun Pharmaceutical Industries Ltd. in India. The medication must be stored refrigerated between 2° C to 8° C and must be discarded if unused. The sheet also includes dosage and safety information.*

This text provides instructions for the use of Doxorubicin Hydrochloride liposome injection diluted with 5% Dextrose Injection, USP. It includes details of the dosage and storage instructions along with the cautionary note that the drug is a cytotoxic agent. The liposomal formulation must not be substituted and should only be administered after dilution. The drug must be kept refrigerated, and the vial should be retained in its carton until use. It also lists the manufacturer and distributor information along with the lot and expiration date.*

This is information about Doxorubicin Hydrochloride Liposome Injection, a cytotoxic agent used in intravenous infusion. It should be diluted before administration and it is a liposomal formulation. The usual dosage is not available, and it should be discarded if not used. The medication should be diluted with 5% Dextrose Injection, USP. It is distributed by Sun Pharmaceutical Industries Inc. from Cranbury, NJ, and manufactured by Sun Pharmaceutical Industries Limited from India. It is stored in a refrigerator between 2°C and 8°C and cannot be frozen. The rest of the text is unknown or illegible.*

This is a description of a medication called "DOXOrubicin Hydrochloride" which is administered through intravenous infusion only. The medication is sold in a 25 mL single-dose vial and distributed by Sun Pharmaceutical Industries. It is a cytotoxic agent that must be diluted before use. The dosage information can be found in the prescribing information. It is a liposomal formulation and should not be substituted. It must be stored in a refrigerator at a temperature of 2°C to 8°C (36°F to 46°F) and should not be frozen. The provided lot number is GUJDRUBS2839.*

This is a representation of a pegylated liposome, with MPEG-DSPE coating, an aqueous core entrapping doxorubicin HCI, and a liposomal bilayer.*

This text appears to provide results from a clinical trial comparing the use of Doxorubicin+Bortezomib with Bortezomib alone. The trial involved a total of 646 subjects, and found a statistically significant improvement in outcomes for the combination treatment, with an HR (hazard ratio) of 0.55 (95% CI 0.43, 0.71) and a p-value < 0.0001. The data is presented in a graph showing time (in months) and the number of subjects at risk for each treatment option.*

The text describes the structural formula of HSPC which has a combination of nitrogen, oxygen, carbon, and hydrogen elements in it. The element's number range from 14 to 16.*